SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-16-090797
Filing Date
2016-01-21
Accepted
2016-01-21 15:19:35
Documents
1
Period of Report
2016-01-19

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3892
  Complete submission text file 0001104659-16-090797.txt   5483
Mailing Address 40 WASHINGTON STREET SUITE 220 WELLESLEY HILLS MA 02481
Business Address
DELUCCIA ROBERT J (Reporting) CIK: 0001127423 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36351 | Film No.: 161353377
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 61 BROADWAY SUITE 1905 NEW YORK NY 10006
Business Address 61 BROADWAY SUITE 1905 NEW YORK NY 10006 212-269-2834
Dipexium Pharmaceuticals, Inc. (Issuer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1